Meningococcal Vaccines Market Size, Share & Industry Analysis, By Technology (Recombinant/Conjugate/Subunit, Inactivated, and Others), By Type (MenACWY Vaccines, MenB Vaccines, MenABCWY Vaccines, and Others), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113758

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Regulatory Scenarios, By Key Countries/Regions
2. Vaccination Coverage- By Key Countries/ Regions
3. Government Immunization Programs for Meningitis, By Key Countries/ Regions
4. Technological Advancements in Meningococcal Vaccines Market
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
Global Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. GSK plc
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Merck & Co., Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Serum Institute of India Pvt. Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Novartis AG
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Walvax Biotechnology Co., Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Hualan Biological Vaccine Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Bio Farma
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. BioNet-Asia.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Regulatory Scenarios, By Key Countries/Regions
2. Vaccination Coverage- By Key Countries/ Regions
3. Government Immunization Programs for Meningitis, By Key Countries/ Regions
4. Technological Advancements in Meningococcal Vaccines Market
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
Global Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Meningococcal Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Technology
  1. Recombinant/Conjugate/Subunit
  2. Inactivated
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. MenACWY Vaccines
  2. MenB Vaccines
  3. MenABCWY Vaccines
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. GSK plc
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Merck & Co., Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Serum Institute of India Pvt. Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Novartis AG
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Walvax Biotechnology Co., Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Hualan Biological Vaccine Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Bio Farma
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. BioNet-Asia.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Meningococcal Vaccines Market Revenue Breakdown (USD billion, %) By Region, 2024 & 2032

Figure 2: Global Meningococcal Vaccines Market Value Share (%), By Technology, 2024 & 2032

Figure 3: Global Meningococcal Vaccines Market Value Share (%), By Type, 2024 & 2032

Figure 4: Global Meningococcal Vaccines Market Value Share (%), By Age Group, 2024 & 2032

Figure 5: Global Meningococcal Vaccines Market Value Share (%), By Distribution Channel, 2024 & 2032

Figure 6: Global Meningococcal Vaccines Market Value Share (%), By Region, 2024 & 2032

Figure 7: North America Meningococcal Vaccines Market Value (USD billion), By Technology, 2024 & 2032

Figure 8: North America Meningococcal Vaccines Market Value Share (%), By Technology, 2024

Figure 9: North America Meningococcal Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 10: North America Meningococcal Vaccines Market Value Share (%), By Type, 2024

Figure 11: North America Meningococcal Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 12: North America Meningococcal Vaccines Market Value Share (%), By Age Group, 2024

Figure 13: North America Meningococcal Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 14: North America Meningococcal Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 15: North America Meningococcal Vaccines Market Value (USD billion), By Country, 2024 & 2032

Figure 16: North America Meningococcal Vaccines Market Value Share (%), By Country, 2024

Figure 17: Europe Meningococcal Vaccines Market Value (USD billion), By Technology, 2024 & 2032

Figure 18: Europe Meningococcal Vaccines Market Value Share (%), By Technology, 2024

Figure 19: Europe Meningococcal Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 20: Europe Meningococcal Vaccines Market Value Share (%), By Type, 2024

Figure 21: Europe Meningococcal Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 22: Europe Meningococcal Vaccines Market Value Share (%), By Age Group, 2024

Figure 23: Europe Meningococcal Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 24: Europe Meningococcal Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 25: Europe Meningococcal Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 26: Europe Meningococcal Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 27: Asia Pacific Meningococcal Vaccines Market Value (USD billion), By Technology, 2024 & 2032

Figure 28: Asia Pacific Meningococcal Vaccines Market Value Share (%), By Technology, 2024

Figure 29: Asia Pacific Meningococcal Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 30: Asia Pacific Meningococcal Vaccines Market Value Share (%), By Type, 2024

Figure 31: Asia Pacific Meningococcal Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 32: Asia Pacific Meningococcal Vaccines Market Value Share (%), By Age Group, 2024

Figure 33: Asia Pacific Meningococcal Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 34: Asia Pacific Meningococcal Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 35: Asia Pacific Meningococcal Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 36: Asia Pacific Meningococcal Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Latin America Meningococcal Vaccines Market Value (USD billion), By Technology, 2024 & 2032

Figure 38: Latin America Meningococcal Vaccines Market Value Share (%), By Technology, 2024

Figure 39: Latin America Meningococcal Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 40: Latin America Meningococcal Vaccines Market Value Share (%), By Type, 2024

Figure 41: Latin America Meningococcal Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 42: Latin America Meningococcal Vaccines Market Value Share (%), By Age Group, 2024

Figure 43: Latin America Meningococcal Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 44: Latin America Meningococcal Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 45: Latin America Meningococcal Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 46: Latin America Meningococcal Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 47: Middle East & Africa Meningococcal Vaccines Market Value (USD billion), By Technology, 2024 & 2032

Figure 48: Middle East & Africa Meningococcal Vaccines Market Value Share (%), By Technology, 2024

Figure 49: Middle East & Africa Meningococcal Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 50: Middle East & Africa Meningococcal Vaccines Market Value Share (%), By Type, 2024

Figure 51: Middle East & Africa Meningococcal Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 52: Middle East & Africa Meningococcal Vaccines Market Value Share (%), By Age Group, 2024

Figure 53: Middle East & Africa Meningococcal Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 54: Middle East & Africa Meningococcal Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 55: Middle East & Africa Meningococcal Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 56: Middle East & Africa Meningococcal Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 57: Global Meningococcal Vaccines Market Share (%), By Company, 2024

List of Tables

Table 1: Global Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Technology, 2019–2032

Table 2: Global Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 3: Global Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 4: Global Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 5: Global Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Region, 2019-2032

Table 6: North America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Technology, 2019–2032

Table 7: North America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 8: North America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 9: North America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 10: North America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: Europe Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Technology, 2019–2032

Table 12: Europe Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 13: Europe Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 14: Europe Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 15: Europe Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Technology, 2019–2032

Table 17: Asia Pacific Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 18: Asia Pacific Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 19: Asia Pacific Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 20: Asia Pacific Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Latin America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Technology, 2019–2032

Table 22: Latin America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 23: Latin America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 24: Latin America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 25: Latin America Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 26: Middle East & Africa Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Technology, 2019–2032

Table 27: Middle East & Africa Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 28: Middle East & Africa Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 29: Middle East & Africa Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 30: Middle East & Africa Meningococcal Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 161

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Vaccines Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com